<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181022041418N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-06-03</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of grape seed extract effect on oral mucositis in patients with a history of head and neck radiotherapy</public_title>
      <acronym>G.S.E</acronym>
      <scientific_title>Evaluation of adjunctive effect grape seed extract(GSE) on oral mucositis in patients with a history of head and neck radiotherapy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-04-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34872</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: At first 50 patients that have investigation standards  are identified.Two types of mouthwash are prepared; type 1 is grape seed extract mouthwash(25 bottles) and type 2 is placebo(25 bottles).Both patient and researcher doesn,t aware that use which type of mouthwash; only the producer of mouthwash can recognize the type of mouthwash with special codes.
In the first day of radiotherapy each patient randomizely receive a bottle of mouthwash to use for two weeks.
finally in the group study we have 50 patients that 25 of them have received grape seed extract mouth wash(intervention group) and 25 patients have received placebo(control group), Blinding description: Two types of mouthwashes are being prepared; type 1 is grape seed extract mouthwash and type 2 is placebo.Both patient and researcher don;t aware about the type of mouthwash; only the producer can recognize the type of mouthwash by special codes.</study_design>
      <phase>3</phase>
      <hc_freetext>Post Radiation Mucositis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:25 patients whom will be treated  under head and neck radiotherapy are being recognized and they receive 2% grape seed extract mouth wash which has been produced by Tabriz Drug Applied Center, patients use mouthwash everyday 3 times and each time for 3 minutes during 2 weeks.Patients are being examined in first-5th-10th-14th days and we record the observations. Intervention 2: Control group:25 patients whom will be treated under head and neck radiotherapy are being recognized and they receive placebo which has been produced by Tabriz Drug Applied Center. Patients use placebo everyday during radiotherapy 3 times and each time for 3 minutes.Patients use placebo for 2 weeks and be examined in first-5th-10th-14th days and observations be recorded.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
We share only the  mucositis changes after using mouthwash.

When:
Data will be accessible one year after printing of the results.

To whom:
Both researchers and mouthwash producer companies can access the documents.

Conditions:
In similar studies in patients with history of head and neck radiotherapy  by changing the concentration of mouthwash and longer follow up it is possible.Also it is possible for evaluation the other effects of grape seed extract.

Where to obtain:
1-Dr.Hosein Babaei Drug Applied Research Center Golgasht Ave,Tabriz
Tel:04133363311 Email:babaei42@yahoo.com
2-Dr.Javad Ahmadi Dentistry faculty Golgasht Ave, Tabriz Tel:09144476091 Email:ahmadiadeh90@gmail.com

How to obtain:
At first the applicant send her/his requisition to one of respondents and after surveying and confirmation of identity and ask about the intentions, the documents are available for him.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Hossein Eslami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental facualty,Golgasht Ave,Azadi Blvd</address>
        <city>Tariz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166616471</zip>
        <telephone>+98 41333559659</telephone>
        <email>eslamihosein56@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Hossein Eslami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dentistry Faculty, Golgasht Ave</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166616471</zip>
        <telephone>+98 41333559659</telephone>
        <email>eslamihosein56@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Complete consciousness
Ability of reading and writing
Oral mucus healthy
Total radiation more than 60gray in radiotherapy duration and 2gray radiation everyday</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Respiratory system diseases and asthma
Diabetes
Autoimmune diseases
Fever and Neutropenia
Continuous usage of analgesics
Narcotic drug usage
Antibiotics usage
Using another mouthwash during investigation
Chemotherapy during investigation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K12.33</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Oral mucositis (ulcerative) due to radiation</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:25 patients whom will be treated  under head and neck radiotherapy are being recognized and they receive 2% grape seed extract mouth wash which has been produced by Tabriz Drug Applied Center, patients use mouthwash everyday 3 times and each time for 3 minutes during 2 weeks.Patients are being examined in first-5th-10th-14th days and we record the observations.</i_keyword>
      <i_keyword>Control group:25 patients whom will be treated under head and neck radiotherapy are being recognized and they receive placebo which has been produced by Tabriz Drug Applied Center. Patients use placebo everyday during radiotherapy 3 times and each time for 3 minutes.Patients use placebo for 2 weeks and be examined in first-5th-10th-14th days and observations be recorded.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mucositis intensity. Timepoint: First-5th-10th-14th days after mouthwash using. Method of measurement: Mucositis grading 0-4.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-09-22</approval_date>
        <contact_name>Ethics committee of Tabriz Univercity of Medical Sciences</contact_name>
        <contact_address>Research-vice third floor,No 2 medical sciences Building Golgasht Ave Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
